The Translational Awards from the British Heart Foundation support the translation of UK cardiology innovation to commercial applications. The scheme supports the development of technologies with transformative potential from the proof-of-concept stage to being ready for the commercial market. The primary applicant must be a researcher at a UK research institution. Individuals or teams from commercial organisations can apply as collaborators. The projects may cover any type of technology, including:
- Novel therapeutics (small molecules or biologics)
- Drug repurposing
- Surgical techniques
- Imaging technologies
- Digital solutions
- Cell therapy and regenerative medicine
The grant provides up to 750,000 GBP for up to 3 years (direct costs only).
The next preliminary applications are due on December 6, 2023.
December 6, 2023